3SBio Inc. is a biotechnology company. The Company is engaged in the development, production, marketing and sale of pharmaceuticals. The Company's products include TPIAO, EPIAO, IV Iron Sucrose, Intefen, Inleusin, SEPO, Sparin, metadoxine, Docetaxel Anastrozole Azasetron, Qiming Keli, YI LI XI, MAN DI, LAIZI, DI SU, LAI DUO FEI, Liranaftate and Amikacin. TPIAO is a recombinant human thrombopoietin (rhTPO) product. In addition, the Company has approximately eight other products in nephrology, oncology and other therapeutic areas. The Company maintains operation facilities in Shenyang (China), Benxi (China), and Shenzhen (China), as well as in Como, Italy. The Company's markets and sells its pharmaceutical products in over 30 provinces, autonomous regions and special municipalities, as well as in various foreign countries and regions. The Company sells its products to over 3,400 hospitals and medical institutions.